NCT01738373
- Conditions
- Blood Protein Disorders, Bone Marrow / Autologous Transplants, Cardiovascular Diseases, +15 more
- Locations
-
- Marseille, France
Clinical trial condition
Neoplasms, Plasma Cell
Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.
2,604 public trials
547 recruiting studies
Neoplasms, Plasma Cell trial results
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Northwestern Medical Faculty Foundation Chicago, Illinois, United States
- Northwestern Memorial Hospital/Main Labs Chicago, Illinois, United States
- University of Kansas Medical Center Kansas City, Kansas, United States
- University of Kansas Cancer Center and Medical Pavilion Westwood, Kansas, United States
NCT00066638
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, DS Stage II Plasma Cell Myeloma, +15 more
- Locations
-
- Montefiore Medical Center - Moses Campus The Bronx, New York, United States
Completed
Protocol of the Combination of Bortezomib and Tipifarnib for Relapsed or Refractory Multiple Myeloma
NCT00972712
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- City of Hope Cancer Institute Duarte, California, United States
- Emory University Winship Cancer Institute Atlanta, Georgia, United States
- Princess Margaret Cancer Center Toronto, Ontario, Canada
NCT00002548
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
- CCOP - Colorado Cancer Research Program, Inc. Denver, Colorado, United States
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States
NCT00416273
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Augsburg, Germany
- Bamberg, Germany
- Berg, Germany
- Berlin, Germany
NCT00003416
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- MBCCOP - University of South Alabama Mobile, Alabama, United States
- CCOP - Greater Phoenix Phoenix, Arizona, United States
- Veterans Affairs Medical Center - Phoenix (Hayden) Phoenix, Arizona, United States
- Veterans Affairs Medical Center - Tucson Tucson, Arizona, United States
NCT00352443
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +43 more
- Locations
-
- USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
- University of California Davis Cancer Center Sacramento, California, United States
- University of Colorado Cancer Center at UC Health Sciences Center Aurora, Colorado, United States
- Lucille P. Markey Cancer Center at University of Kentucky Lexington, Kentucky, United States
Completed
S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis
NCT00002849
- Conditions
- Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +17 more
- Locations
-
- Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States
- Veterans Affairs Medical Center - San Francisco San Francisco, California, United States
- CCOP - Christiana Care Health Services Wilmington, Delaware, United States
- Lombardi Cancer Center Washington D.C., District of Columbia, United States
NCT00416208
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Bamberg, Germany
- Berg, Germany
- Berlin, Germany
- Bremen, Germany